Risk of upper gastrointestinal bleeding among users of antidepressant compounds and the binding and selectivity characteristics of those compounds for the human serotonin transporter
 
Drug Adjusted Relative Risk* (95% CI) Geometric mean of equilibrium dissociation constant for serotonin transporter
KD ± SEM (nmol)
Selectivity for serotonin transporter over norepinephrine transporter Selectivity for serotonin transporter over dopamine transporter
Trazodone* 8.6 (2.1 to 35.1) 160 (20) 53 46
Paroxetine* 4.3 (2.2 to 8.3) 0.13 (0.01) 300 3700
Sertraline* 3.9 (1.1 to 8.3) 0.29 (0.01) 1400 86
Fluoxetine* 2.5 (1.4 to 4.7) 0.81 (0.02) 300 4300
Clomipramine* 2.1 (0.9 to 5.1) 0.28 (0.01) 130 7800
Imipramine 2.1 (0.7 to 6.2) 1.40 (0.03) 27 6100
Amitriptyline  1.9 (1.2 to 2.9) 4.30 (0.12) 8.1 760
Lofepramine 1.8 (0.8 to 4.0) 70 (4) 0.077 260
Trimipramine 1.2 (0.2 to 6.0) 149 (6) 16 25
Mianserine 1.1 (0.1 to 9.2) 4000 (300) 0.018 0.24
Dothiepin 1.0 (0.6 to 1.6) 8.6 (0.4) 5.3 620
Nortriptyline 0.3 (0.0 to 3.5) 18 (1) 0.24 62
Fluvoxamine* Not available 2.2 (0.2) 580 4100
Venlafaxine Not available 8.9 (0.3) 120 1000
Chlorpheniramine† Not available 15.2 (0.8) 94.7 69.7
Diphenhydramine† Not available 3800 (400) 0.25 0.58

* Compounds classified as selective serotonin reuptake inhibitors by de Abajo et al.4
† H1 antihistamine compounds included for comparative purposes
  Equilibrium dissociation constants and selectivity data derived from those published by Tatsumi et al.7




Access jobs at BMJ Careers
Whats new online at Student 

BMJ